• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The prognostic value of chest X-ray in patients with COVID-19 on admission and when starting CPAP.入院时和开始 CPAP 时的 COVID-19 患者的胸部 X 射线的预后价值。
Clin Med (Lond). 2021 Jan;21(1):e14-e19. doi: 10.7861/clinmed.2020-0576.
2
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.COVID-19 呼吸衰竭的 CPAP 管理:来自住院服务评估的首次定量分析。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000692.
3
RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial.RECOVERY- 呼吸支持:疑似或确诊 COVID-19 呼吸衰竭患者的呼吸策略;持续气道正压通气、高流量鼻氧和标准治疗:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jul 29;21(1):687. doi: 10.1186/s13063-020-04617-3.
4
The role of CPAP as a potential bridge to invasive ventilation and as a ceiling-of-care for patients hospitalized with Covid-19-An observational study.CPAP 作为一种潜在的有创通气桥接手段和 COVID-19 住院患者的治疗上限的作用:一项观察性研究。
PLoS One. 2020 Dec 31;15(12):e0244857. doi: 10.1371/journal.pone.0244857. eCollection 2020.
5
Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patients.在重症监护病房外使用 CPAP 治疗 COVID-19 患者:透析和非透析依赖患者的生存和结局比较。
BMC Nephrol. 2021 Apr 21;22(1):144. doi: 10.1186/s12882-021-02341-x.
6
Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study.持续气道正压通气(CPAP)面罩通气是在 SARS-CoV-2 爆发期间管理大量急性呼吸衰竭患者的一种简单且廉价的选择:一项回顾性队列研究。
PLoS One. 2020 Oct 14;15(10):e0240645. doi: 10.1371/journal.pone.0240645. eCollection 2020.
7
Racial and Ethnic Disparities in Disease Severity on Admission Chest Radiographs among Patients Admitted with Confirmed Coronavirus Disease 2019: A Retrospective Cohort Study.种族和民族差异对确诊 2019 年冠状病毒病患者入院时胸部 X 线片疾病严重程度的影响:一项回顾性队列研究。
Radiology. 2020 Dec;297(3):E303-E312. doi: 10.1148/radiol.2020202602. Epub 2020 Jul 16.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre.COVID-19 相关肺炎孕妇应用 CPAP 的可行性及与呼吸衰竭恶化相关的因素:一家三级医疗中心的经验。
PLoS One. 2021 Oct 19;16(10):e0258754. doi: 10.1371/journal.pone.0258754. eCollection 2021.
10
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.

引用本文的文献

1
Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.血清降钙素原水平与住院 COVID-19 阳性美国退伍军人的机械通气和病死率独立相关-疾病严重程度的潜在标志物。
PLoS One. 2023 Apr 17;18(4):e0284520. doi: 10.1371/journal.pone.0284520. eCollection 2023.
2
Utility of chest radiograph severity scoring in emergency department for predicting outcomes in COVID-19: A study of 1275 patients.胸部 X 线严重程度评分在急诊科预测 COVID-19 结局中的作用:一项 1275 例患者的研究。
Clin Imaging. 2023 Mar;95:65-70. doi: 10.1016/j.clinimag.2022.12.002. Epub 2022 Dec 28.
3
Chest X-ray Does Not Predict the Risk of Endotracheal Intubation and Escalation of Treatment in COVID-19 Patients Requiring Noninvasive Respiratory Support.胸部X光无法预测需要无创呼吸支持的COVID-19患者的气管插管风险和治疗升级情况。
J Clin Med. 2022 Mar 16;11(6):1636. doi: 10.3390/jcm11061636.
4
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research.急性 COVID-19 肺炎管理中的无创呼吸支持:临床实践的考虑因素和研究的优先事项。
Lancet Respir Med. 2022 Feb;10(2):199-213. doi: 10.1016/S2213-2600(21)00414-8. Epub 2021 Nov 9.

本文引用的文献

1
Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19.临床和胸部放射摄影特征可预测 COVID-19 中青年患者的结局。
Radiology. 2020 Oct;297(1):E197-E206. doi: 10.1148/radiol.2020201754. Epub 2020 May 14.
2
Use of non-invasive ventilation for patients with COVID-19: a cause for concern?新型冠状病毒肺炎患者使用无创通气:值得关注吗?
Lancet Respir Med. 2020 Jun;8(6):e45. doi: 10.1016/S2213-2600(20)30181-8. Epub 2020 Apr 21.
3
COVID-19 pneumonia: ARDS or not?新冠肺炎:是否为急性呼吸窘迫综合征?
Crit Care. 2020 Apr 16;24(1):154. doi: 10.1186/s13054-020-02880-z.
4
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
5
COVID-19: Respiratory support outside the intensive care unit.新型冠状病毒肺炎:重症监护室外的呼吸支持
Lancet Respir Med. 2020 Jun;8(6):538-539. doi: 10.1016/S2213-2600(20)30176-4. Epub 2020 Apr 9.
6
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19.COVID-19 阳性患者的胸部 X 线表现的频率和分布。
Radiology. 2020 Aug;296(2):E72-E78. doi: 10.1148/radiol.2020201160. Epub 2020 Mar 27.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Semi-quantitative visual assessment of chest radiography is associated with clinical outcomes in critically ill patients.半定量胸部 X 线摄影评估与危重症患者的临床结局相关。
Respir Res. 2019 Oct 12;20(1):218. doi: 10.1186/s12931-019-1201-0.
10
Early prediction of noninvasive ventilation failure in COPD patients: derivation, internal validation, and external validation of a simple risk score.慢性阻塞性肺疾病(COPD)患者无创通气失败的早期预测:一种简单风险评分的推导、内部验证和外部验证
Ann Intensive Care. 2019 Sep 30;9(1):108. doi: 10.1186/s13613-019-0585-9.

入院时和开始 CPAP 时的 COVID-19 患者的胸部 X 射线的预后价值。

The prognostic value of chest X-ray in patients with COVID-19 on admission and when starting CPAP.

机构信息

Ealing Hospital, London, UK

Ealing Hospital, London, UK.

出版信息

Clin Med (Lond). 2021 Jan;21(1):e14-e19. doi: 10.7861/clinmed.2020-0576.

DOI:10.7861/clinmed.2020-0576
PMID:33479078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7850226/
Abstract

OBJECTIVE

The objective was to explore if chest X-ray severity, assessed using a validated scoring system, predicts patient outcome on admission and when starting continuous positive pressure ventilation (CPAP) for COVID-19.

DESIGN

The study was a retrospective case-controlled study.

PARTICIPANTS

There were 163 patients with COVID-19 deemed candidates for CPAP on admission, including 58 who subsequently required CPAP.

OUTCOME MEASURES

On admission, we measured the proportion of patients meeting a composite 'negative' outcome of requiring CPAP, intubation or dying versus successful ward-based care. For those escalated to CPAP, 'negative' outcomes were intubation or death versus successful de-escalation of respiratory support.

RESULTS

Our results were stratified into tertiles, those with 'moderate' or 'severe' X-rays on admission had significantly higher odds of negative outcome versus 'mild' (odds ratio (OR) 2.32; 95% confidence interval (CI) 1.121-4.803; p=0.023; and OR 3.600; 95% CI 1.681-7.708; p=0.001, respectively). This could not be demonstrated in those commencing CPAP (OR 0.976; 95% CI 0.754-1.264; p=0.856).

CONCLUSIONS

We outline a scoring system to stratify X-rays by severity and directly link this to prognosis. However, we were unable to demonstrate this association in the patients commencing CPAP.

摘要

目的

本研究旨在探讨使用经过验证的评分系统评估的胸部 X 射线严重程度是否可预测 COVID-19 患者入院时和开始持续气道正压通气(CPAP)时的预后。

设计

本研究为回顾性病例对照研究。

参与者

共有 163 名 COVID-19 患者被认为适合入院时接受 CPAP,其中 58 名患者随后需要 CPAP。

结局测量

入院时,我们测量了符合 CPAP、插管或死亡复合“阴性”结局的患者比例与成功的基于病房的护理相比。对于那些升级为 CPAP 的患者,“阴性”结局为插管或死亡与呼吸支持的成功降级相比。

结果

我们的结果分层为三分位数,入院时 X 射线显示“中度”或“重度”的患者与“轻度”相比,发生阴性结局的可能性显著更高(比值比(OR)2.32;95%置信区间(CI)1.121-4.803;p=0.023;和 OR 3.600;95% CI 1.681-7.708;p=0.001)。在开始使用 CPAP 的患者中,这一点无法得到证明(OR 0.976;95% CI 0.754-1.264;p=0.856)。

结论

我们提出了一种评分系统,根据严重程度对 X 射线进行分层,并直接将其与预后联系起来。然而,我们未能在开始使用 CPAP 的患者中证明这种关联。